HomeInsightsEPS

Concord Biotech Ltd EPS

Concord Biotech Ltd EPS

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

3.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Concord Biotech Ltd

NSE: CONCORDBIO

EPS

₹ 31.35

Last updated on: Nov 22, 2024

Key Highlights

  • The Earning per Share of Concord Biotech Ltd is ₹ 31.35 as of 22 Nov 24 .
  • The earning per share of Concord Biotech Ltd changed from ₹ 4.71 to ₹ 9.15 over 10 quarters. This represents a CAGR of 30.42% .

Historical Earning per Share of Concord Biotech Ltd

No data available

* All values are in

Company Fundamentals for Concord Biotech Ltd

Market Cap

21,253 Cr

EPS

31.4

P/E Ratio (TTM) *

64.8

P/B Ratio (TTM) *

13.4

Day’s High *

2049.85

Day’s Low

1959.2

DTE *

0.0

ROE *

20.6

52 Week High

2658.0

52 Week Low

1221.0

ROCE *

27.8

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242031.55
21 Nov 20241988.55
19 Nov 20241898.5
18 Nov 20241910.05
14 Nov 20241893.25
13 Nov 20241853.45
12 Nov 20241860.35
11 Nov 20241877.85
08 Nov 20241851.85
07 Nov 20241828.7

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

21,253

Asset Value

655

31.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Concord Biotech Ltd3121,253
Sun Pharmaceuticals Industries Ltd464,31,352
Divis Laboratories Ltd691,59,265
Cipla Ltd571,20,033
Torrent Pharmaceuticals Ltd511,07,301
Mankind Pharma Ltd521,02,231

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Biotech Ltd News Hub

News

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 Novembe...

Read more

06 Nov 202409:53

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

29 Aug 202414:30

News

Concord Biotech schedules board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 9 August 2...

Read more

31 Jul 202414:25

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for EPS of Concord Biotech Ltd

What is the EPS of Concord Biotech Ltd stock?

The Earnings Per Share (EPS) of Concord Biotech Ltd is 31.35. An EPS is the amount of net income attributed to each share of a common stock.

How is Concord Biotech Ltd EPS calculated?

The EPS of Concord Biotech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Concord Biotech Ltd report its EPS?

Concord Biotech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Concord Biotech Ltd EPS?

Factors that influence the EPS of Concord Biotech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Concord Biotech Ltd EPS growth indicate future performance?

Yes, consistent growth in Concord Biotech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*